Antibodies targeting glucose transporter GLUT1 developed through the methods of Phage Display

Simple item page
dc.contributor.advisorTeyra, Joan, juhendaja
dc.contributor.advisorTenson, Tanel, juhendaja
dc.contributor.authorPlanken, Jaan Eerik
dc.contributor.otherTartu Ülikool. Loodus- ja täppisteaduste valdkond
dc.contributor.otherTartu Ülikool. Tehnoloogiainstituut
dc.date.accessioned2024-06-17T07:35:40Z
dc.date.available2024-06-17T07:35:40Z
dc.date.issued2024
dc.description.abstractCancer immunotherapy has emerged as a major treatment approach to combat malignant cells. Among the potential targets, the glucose transporter 1 (GLUT1) stands out due to its role in facilitating the increased glucose uptake characteristic of cancer cells. In this thesis, we use the methods of phage display technology to isolate GLUT1-specific antibodies from a diverse phage library constructed from a previously immunized chickens spleen cells. Through four rounds of panning against a GLUT1-overexpressing virus-like particle (VLP), with each round increasing in stringency, we were able to identify 27 unique antibody sequences. All obtained unique antibodies show great specificity towards the GLUT1 VLP, with signals averaging 11 times higher, on an ELISA based binding assay, in comparison to an off-target antigen control.
dc.identifier.urihttps://hdl.handle.net/10062/99634
dc.language.isoen
dc.publisherTartu Ülikool
dc.subjectM13 Phage Display
dc.subjectAntibodies
dc.subjectCancer immunotherapy
dc.subjectELISA
dc.subject.otherbakalaureusetöödet
dc.titleAntibodies targeting glucose transporter GLUT1 developed through the methods of Phage Display
dc.title.alternativeAntikehade leidmine glükoosi transporteri GLUT1 vastu kasutades faagi displei tehnoloogiat
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JaanEerikPlanken_ST.pdf
Size:
2.05 MB
Format:
Adobe Portable Document Format
Download

Collections

Science and Technology - Bachelor's theses. Kuni 2024